MedPath

Efficacy and Safety of 3% Minoxidil Lotion for Beard Enhancement

Phase 4
Completed
Conditions
Beard Enhancement
Interventions
Drug: 3 % Minoxidil lotion
Drug: Placebo
Registration Number
NCT02275832
Lead Sponsor
Mae Fah Luang University Hospital
Brief Summary

The purpose of this study is to determine efficacy and safety of 3% minoxidil lotion for beard enhancement.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
Male
Target Recruitment
48
Inclusion Criteria
  • Healthy male
Exclusion Criteria
  • serious underlying diseases.
  • history of beard/ hair treatment before 6 months
  • history of surgery or trauma on beard area.
  • history of minoxidil allergy

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Minoxidil3 % Minoxidil lotion3% Minoxidil lotion is applied twice daily to the beard.
PlaceboPlaceboPlacebo is applied twice daily to beard.
Primary Outcome Measures
NameTimeMethod
The change of global photographic assessment after 16 weeks from baselinebaseline and 16 weeks
Secondary Outcome Measures
NameTimeMethod
The change in number of hairs after 16 weeks from baselinebaseline and 16 weeks

Trial Locations

Locations (1)

MFL University Hospital (Bangkok)

🇹🇭

Bangkok, Thailand

© Copyright 2025. All Rights Reserved by MedPath